Skip to main content
SpringerLink
Log in

Gli adenomi ipofisari in gravidanza

  • RASSEGNA
  • Published:
L'Endocrinologo Aims and scope

Sommario

La gravidanza influisce su morfologia e funzione ipofisarie e tali modificazioni possono rendere complessa non solo la diagnosi di patologie ipofisarie di nuova insorgenza, ma anche il follow-up e la gestione di adenomi ipofisari, secernenti e non, diagnosticati prima della gravidanza. I dati attualmente disponibili su andamento, gestione e esito della gravidanza sono prevalentemente concentrati sulle pazienti con adenomi ipofisari PRL e GH-secernenti. La gestione di queste pazienti durante la gravidanza dipende da tipologia, dimensioni ed estensione dell’adenoma e andrebbe preferibilmente affidata a Centri dedicati alla diagnosi e cura delle patologie ipofisarie. In questa Rassegna si descriveranno in breve sia le modificazioni morfo-funzionali della ghiandola ipofisaria in corso di gravidanza sia le modalità di gestione per ciascuna tipologia di adenoma ipofisario.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Bibliografia

  1. Karaca Z, Kelestimur F (2010) Pregnancy and other pituitary disorders (including GH deficiency). Best Pract Res Clin Endocrinol Metab 25:897–910

    Article  Google Scholar 

  2. Hu Y, Ding Y, Yang M et al. (2018) Serum prolactin levels across pregnancy and the establishment of reference intervals. Clin Chem Lab Med 56(5):803–807

    Article  CAS  Google Scholar 

  3. Alexander EK, Pearce EN, Brent GA et al. (2017) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27(3):315–389

    Article  PubMed  Google Scholar 

  4. Lindsay JR, Nieman LK (2005) The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26(6):775–799

    Article  CAS  PubMed  Google Scholar 

  5. Persechini ML, Gennero I, Grunenwald S et al. (2015) Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function. Pituitary 18(4):461–464

    Article  CAS  PubMed  Google Scholar 

  6. Molitch ME (2015) Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. Eur J Endocrinol 172(5):R205–R213

    Article  CAS  PubMed  Google Scholar 

  7. Melmed S, Casanueva FF, Hoffman AR et al. (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(2):273–288

    Article  CAS  PubMed  Google Scholar 

  8. Caron P, Broussaud S, Bertherat J et al. (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680–4687

    Article  CAS  PubMed  Google Scholar 

  9. Cheng S, Grasso L, Martinez-Orozco JA et al. (2012) Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf) 76(2):264–271

    Article  Google Scholar 

  10. Chanson P, Vialon M, Caron P (2019) An update on clinical care for pregnant women with acromegaly. Exp Rev Endocrinol Metab 14(2):85–96

    Article  CAS  Google Scholar 

  11. Hannon AM, O’Shea T, Thompson CA et al. (2019) Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. Eur J Endocrinol 180(4):K21–K29

    Article  CAS  PubMed  Google Scholar 

  12. Muhammad A, Neggers SJ, van der Lely AJ (2017) Pregnancy and acromegaly. Pituitary 20(1):179–184

    Article  CAS  PubMed  Google Scholar 

  13. van der Lely AJ, Gomez R, Heissler JF et al. (2015) Pregnancy in acromegaly patients treated with pegvisomant. Endocrine 49(3):769–773

    Article  PubMed  Google Scholar 

  14. Katznelson L, Laws ER Jr, Melmed S et al. (2014) Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951

    Article  CAS  PubMed  Google Scholar 

  15. Brue T, Amodru V, Castinetti F (2018) Management of endocrine disease: management of Cushing’s syndrome during pregnancy: solved and unsolved questions. Eur J Endocrinol 178(6):R259–266

    Article  CAS  PubMed  Google Scholar 

  16. Beck-Peccoz P, Lania A, Beckers A et al. (2013) European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2:76–82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Araujo PB, Vieira Neto L, Gadelha MR (2015) Pituitary tumor management in pregnancy. Endocrinol Metab Clin N Am 44(1):181–197

    Article  Google Scholar 

  18. Lindsay JR, Jonklaas J, Oldfield EH et al. (2005) Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 90:3077–3083

    Article  CAS  PubMed  Google Scholar 

  19. Aron DC, Schnall AM, Sheeler LR (1990) Cushing’s syndrome and pregnancy. Am J Obstet Gynecol 162:244–252

    Article  CAS  PubMed  Google Scholar 

  20. Pivonello R, De Martino MC, Auriemma RS et al. (2014) Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. J Endocrinol Invest 37(2):99–112

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. U.O. Endocrinologia, Diabetologia e Andrologia Medica, IRCCS Humanitas Research Hospital, Dipartimento di Scienze Biomediche, Humanitas University, Rozzano, Italia

    Nazarena Betella, Walter Vena, Emilia Biamonte, Elisabetta Lavezzi & Andrea Lania

Authors
  1. Nazarena Betella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walter Vena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emilia Biamonte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabetta Lavezzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrea Lania
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Lania.

Ethics declarations

Conflitti di interesse

Gli autori Nazarena Betella, Walter Vena, Emilia Biamonte, Elisabetta Lavezzi e Andrea Lania dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studio sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da Alessandro Peri.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Materiale elettronico supplementare

I link al materiale elettronico supplementare sono elencati qui sotto.

(DOC 34 kB)

(DOC 47 kB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Betella, N., Vena, W., Biamonte, E. et al. Gli adenomi ipofisari in gravidanza. L'Endocrinologo 21, 246–251 (2020). https://doi.org/10.1007/s40619-020-00765-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-020-00765-5

Parole chiave

Search

Navigation